The Food and Drug Administration (FDA) has granted expanded access for treatments employing the drug commonly known as “ecstasy,” or MDMA.
The Multidisciplinary Association for Psychedelic Studies (MAPS) announced Friday that the FDA has expanded access to the drug for use in treatment, so MDMA-assisted psychotherapy will soon be available to patients outside of research and clinical trials.
Studies shown so far offer a lot of hope, especially to our military veteran population.
Iraq War veteran Jonathan Lubecky is among the most inspirational stories of MDMA-assisted psychotherapy’s potential.
Despite a multitude of treatments, Lubecky attempted suicide on five separate occasions.